Stocks

My view of HSBC (HSBA) to date has largely been along the lines of “it’s not a great business, but it’s not as bad as the market implies either”. Admittedly, initiating coverage during the COVID sell-off made that a fairly easy call to make, with the stock slumping to very…

BP (BP) shares have done nicely since my last update in October 2020, gaining over 60% from what was then a 25-year low point. Though a welcome rebound, a couple of things still appear to weigh on the stock, the first of which is the lingering impact of last year’s…

In a way, Standard Chartered (STAN) sums up the problem with bank stocks. I say that because on paper it looks like a very good long-term proposition. The bank is largely an Asian and emerging market player for one, while it also generates the lion’s share of its income from…

Despite its issues, healthcare giant GlaxoSmithKline (GSK) remains one of the highest quality businesses on the London Stock Exchange. The Glaxo empire, which spans various patented drugs, vaccines and a consumer health segment that owns brands like Sensodyne toothpaste, has generated in excess of £16b worth of free cash flow…

HSBC (HSBA) stock has rallied around 40% since it last appeared on the site back in September. At the time, shares of the global banking giant traded for just over 300p each. That quote represented an almost unprecedented slump that had taken the stock to a circa 25-year low. Of…